4.6 Article Proceedings Paper

Acrolein, IL-6 and CRP as markers of silent brain infarction

Journal

ATHEROSCLEROSIS
Volume 203, Issue 2, Pages 557-562

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2008.07.022

Keywords

Silent brain infarction; Acrolein; Inflammatory markers; Prediction

Ask authors/readers for more resources

We found previously that increased levels of polyamine oxidase (PAO) [acetylpolyamine oxidase (AcPAO) Plus spermine oxidase (SMO)], and acrolein (CH2=CHCHO) are good markers of stroke. We then investigated whether silent brain infarction (SBI) can be detected by measuring acrolein, PAO, or other biomarkers. Several biomarkers were measured in the plasma of 53 normal subjects and 44 subjects with SBI. It was found that the levels of protein-conjugated acrolein (PC-Acro), interleukin-6 (IL-6) and C-reactive protein (CRP) were significantly higher in SBI than in normal Subjects. PAO was slightly higher in SBI than in normal Subjects. Since the probability of SBI was increased with age, values were analyzed including age as a factor. When the combined measurements of PC-Acro, IL-6 and CRP were evaluated together with age using a receiver operating characteristic curve, SBI was indicated with 89% sensitivity and 91% specificity. The results indicate that measurement of PC-Acro together with IL-6 and CRP makes it possible to identify SBI with high sensitivity and specificity. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available